Enabling Human-agent Collaboration To Revolutionize Commercial Analytics

Discover how agentic AI is transforming life sciences commercial analytics in this exclusive report from Axtria Ignite 2025. This report highlights insights from pharmaceutical industry leaders on cutting-edge use cases that deliver measurable returns on investment (ROI) and solutions to critical adoption challenges. It also discusses the organizational capabilities necessary for success and provides global perspectives on AI innovation.

Key insights from the report

• Transformative use cases
  • Integrated AI systems combining structured and unstructured data
  • Real-time sales rep coaching and HCP engagement
  • Multi-language content generation at scale
  • Next-best-action recommendations with explainable AI  

• Overcoming adoption barriers
  • Building trust through semantic architectures and Retrieval-Augmented Generation (RAG) frameworks
  • Addressing organizational culture challenges
  • Implementing safe deployment practices
  • Managing expectations for incremental progress  
    
    
• Global innovation perspectives
  • Why China has an edge in cost-effective AI deployment
  • The unique situation that boosts Australia’s innovation
  • Regulatory considerations across markets

What industry leaders are saying

"In analytics, particularly with agentic AI, what we can do with data exploration, what we can do with pattern recognition, what we can do with physician augmentation, high-purpose analytics, is immense."

"To generate content at scale, especially in an international setting, it's about different languages, translating, and localizing content at scale. It's a big use case."

"There needs to be understanding, buy-in, and advocacy with sponsorship at the highest levels. Without that, it’s a short disaster."

"You have to have a center of excellence where there’s a group of people who are dedicated to standing this thing up. You need your true cross-functional teams, from marketing, from the analytics partners, from field sales."

Download the full report now to unlock insights from executives at Regeneron, Pfizer, AstraZeneca, Novartis, and Mallinckrodt.

Contact us at connect@axtria.com with any questions.

FAQs